Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Skin pigmentation treatment medicine

A technology for skin pigmentation and medicine, which is applied in the field of medicine and can solve problems such as low-key agent output rate

Active Publication Date: 2016-02-03
资医堂疤斑痘广东皮肤研究院有限合伙
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these materials have several problems, such as too low swap yield, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Skin pigmentation treatment medicine
  • Skin pigmentation treatment medicine
  • Skin pigmentation treatment medicine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0130] The ratio of each component and each step in the preparation method of the oral liquid for oral administration of the present invention have a beneficial influence on the drug effect. The inventors unexpectedly found that the oral liquid for oral administration of the present invention can inhibit the activity of tyrosinase, thereby inhibiting the synthesis of melanin. In addition, the oral liquid for oral administration of the present invention has a variety of compound vitamins, which can quickly decompose melanin. In addition, the oral liquid for oral administration of the present invention can also nourish and strengthen the five internal organs, enhance human body resistance, and taste good , Fast absorption. Thus, the advantageous effects of the present invention are provided.

[0131] Yet another aspect of the present invention relates to an external application ointment, which includes the following compositions by weight in 100 parts by weight: 15-45 parts by ...

Embodiment

[0139] Table 1 is the parts by weight of each material composition in composition A; Table 2 is the parts by weight of each material composition in composition B; Table 3 is the parts by weight of each material composition in composition C; Table 4 is the composition The parts by weight of each material composition in D; Table 5 is the parts by weight of each material composition in composition E; Table 6 is the parts by weight of each material composition in composition F; Table 7 is the material in the oral liquid embodiment for oral administration Content composition; Table 8 is the composition of substance content in the external application ointment embodiment.

[0140] The parts by weight of each material composition in table 1 composition A

[0141]

[0142] The parts by weight of each material composition in table 2 composition B

[0143]

[0144] The parts by weight of each material composition in table 3 composition C

[0145]

[0146] The parts by weight ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a skin pigmentation treatment medicine. The medicine comprises 20-50 parts of Centella asiatica, 8-30 parts of L-vitamin C, 1-10 parts of white peony root, 1-10 parts of coix seed, 1-10 parts of pearl powder, 1-10 parts of Chinese yam, 1-5 parts of Phymatopsis hastata, 0.5-0.8 parts of Indian Mockstrawberry Herb, 1-5 parts of Herb of Siberian Cocklebur, 1-2.5 parts of Piper betle L., 2-5 parts of Herba Scutellariae Indicae, 10-30 parts of oligopeptides, 5-15 parts of hyaluronic acid, 1-10 parts of nanometer collagens, 5-20 parts of Malaytea Scurfpea Fruit, 0.1-0.3 parts of Fructus Toosendan, 3-5 parts of Radix Morindae officinalis, 3-6 parts of Fructus Rosae Laevigatae, 1-5 parts of Cynara scolymus, 5-10 parts of Radix Codonopsis, 2-5 parts of Chinese wolfberry, 2-5 parts of licorice root, 2-5 parts of Chinese angelica, 5-12 parts of Dendrobium officinale, 5-12 parts of Radix Pseudostellariae, 1-3 parts of Curculigo orchioides, 2-5 parts of Hedyotis diffusa, 10-20 parts of safflower, 3-6 parts of ginger, 2-4 parts of Rhizoma Alpiniae Officinarum, 2-5 parts of rhizome of Whiteback Greenbrier, 1-3 parts of Divaricate Saposhnikovia Root, 5-10 parts of olive oil and 8-12 parts of rose flower.

Description

technical field [0001] The present invention relates to a medicine. More specifically, the content of the present invention relates to a medicine for treating skin pigmentation and an oral liquid for internal use and an ointment for external application prepared therefrom. Background technique [0002] Skin pigmentation is caused by various factors such as internal and external factors, such as hormonal imbalance accompanied by skin inflammation, genetic diseases, and ultraviolet radiation. Freckles, skin darkening after skin inflammation, senile purpura, etc. And skin pigmentation increases with aging and becomes difficult to remove, and is a big trouble especially for middle-aged or elderly people. [0003] The main function of melanin is to scavenge oxygen free radicals to protect the skin from injury. Therefore, a high amount of melanin is understandably indicative of a powerful response of the skin system to protect the skin from physically or chemically toxic substa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/39A61K9/08A61K9/06A61P17/00A61K35/618A61K31/375A61K31/728
Inventor 张作峰
Owner 资医堂疤斑痘广东皮肤研究院有限合伙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products